wetAMD
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration (NCT07607561) | SCAI Therapeutics | 2026-11-01 |
| Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (NCT05407636) | AbbVie | 2022-01-13 |
| Canadian Treat and Extend Analysis Trial With Ranibizumab (NCT02103738) | Novartis Pharmaceuticals | 2013-05-08 |
Track wetAMD automatically
Every clearance here is in the API, with alerts when new ones post.